CL2023000118A1 - Vacuna porcina que combina una o más antígenos. - Google Patents
Vacuna porcina que combina una o más antígenos.Info
- Publication number
- CL2023000118A1 CL2023000118A1 CL2023000118A CL2023000118A CL2023000118A1 CL 2023000118 A1 CL2023000118 A1 CL 2023000118A1 CL 2023000118 A CL2023000118 A CL 2023000118A CL 2023000118 A CL2023000118 A CL 2023000118A CL 2023000118 A1 CL2023000118 A1 CL 2023000118A1
- Authority
- CL
- Chile
- Prior art keywords
- antigens
- combines
- lawsonia intracellularis
- vaccine
- swine vaccine
- Prior art date
Links
- 239000000427 antigen Substances 0.000 title abstract 4
- 102000036639 antigens Human genes 0.000 title abstract 4
- 108091007433 antigens Proteins 0.000 title abstract 4
- 229960005486 vaccine Drugs 0.000 title abstract 2
- 241000282898 Sus scrofa Species 0.000 title 1
- 241001148567 Lawsonia intracellularis Species 0.000 abstract 3
- 241000202347 Porcine circovirus Species 0.000 abstract 2
- 241000700605 Viruses Species 0.000 abstract 2
- 241000204045 Mycoplasma hyopneumoniae Species 0.000 abstract 1
- 241001135989 Porcine reproductive and respiratory syndrome virus Species 0.000 abstract 1
- 244000052769 pathogen Species 0.000 abstract 1
- 230000001717 pathogenic effect Effects 0.000 abstract 1
- 230000001850 reproductive effect Effects 0.000 abstract 1
- 230000000241 respiratory effect Effects 0.000 abstract 1
- 208000011580 syndromic disease Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/105—Delta proteobacteriales, e.g. Lawsonia; Epsilon proteobacteriales, e.g. campylobacter, helicobacter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/295—Polyvalent viral antigens; Mixtures of viral and bacterial antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5256—Virus expressing foreign proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/10011—Circoviridae
- C12N2750/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/10011—Arteriviridae
- C12N2770/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/10011—Arteriviridae
- C12N2770/10071—Demonstrated in vivo effect
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Virology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Organic Chemistry (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Pulmonology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063055947P | 2020-07-24 | 2020-07-24 | |
| EP20196349 | 2020-09-16 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CL2023000118A1 true CL2023000118A1 (es) | 2023-09-08 |
Family
ID=77274829
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CL2023000118A CL2023000118A1 (es) | 2020-07-24 | 2023-01-12 | Vacuna porcina que combina una o más antígenos. |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20230241198A1 (https=) |
| EP (1) | EP4185321A2 (https=) |
| JP (2) | JP7657287B2 (https=) |
| KR (1) | KR20230044474A (https=) |
| CN (1) | CN116157147A (https=) |
| AU (1) | AU2021311726A1 (https=) |
| BR (1) | BR112023001324A2 (https=) |
| CA (1) | CA3185751A1 (https=) |
| CL (1) | CL2023000118A1 (https=) |
| CO (1) | CO2023000299A2 (https=) |
| MX (1) | MX2023001024A (https=) |
| WO (1) | WO2022020593A2 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116036260A (zh) * | 2022-12-30 | 2023-05-02 | 哈药集团生物疫苗有限公司 | 猪圆环病毒、猪肺炎支原体、猪塞内卡病毒三联灭活疫苗及其制备方法和应用 |
| WO2024260953A1 (en) * | 2023-06-23 | 2024-12-26 | Intervet International B.V. | A method of culturing lawsonia intracellularis bacteria |
| CN118477172A (zh) * | 2024-01-09 | 2024-08-13 | 浙江鼎持生物制品有限公司 | 一种猪三联灭活疫苗及其制备方法 |
| CN118894910B (zh) * | 2024-07-24 | 2026-03-06 | 华南农业大学 | 一种PRRSV-GP3-GP5-M+PCV2-TBCap重组蛋白、疫苗及应用 |
Family Cites Families (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2909462A (en) | 1955-12-08 | 1959-10-20 | Bristol Myers Co | Acrylic acid polymer laxative compositions |
| EP0173552B1 (en) | 1984-08-24 | 1991-10-09 | The Upjohn Company | Recombinant dna compounds and the expression of polypeptides such as tpa |
| JP3128133B2 (ja) | 1991-06-06 | 2001-01-29 | スティッチティング セントラール ディールゲネースクンディグ インスティトゥート | 豚の奇病の原因体であるレリスタドエイジェント、それを含むワクチン組成物、豚の奇病の診断キット及び診断方法 |
| US6042830A (en) | 1992-08-05 | 2000-03-28 | Boehringer Ingelheim Vetmedica, Inc. | Viral agent associated with mystery swine disease |
| DK0601062T4 (da) | 1991-08-26 | 2001-03-14 | Univ Minnesota | SIRS-vaccine og diagnosefremgangsmåde |
| AU2696792A (en) | 1991-09-16 | 1993-04-27 | David A Benfield | Vaccine for mystery swine disease and method for diagnosis thereof |
| AU2684792A (en) | 1991-10-14 | 1993-05-21 | Akzo Nobel N.V. | Porcine reproductive respiratory syndrome vaccine and diagnostic |
| DE69522984T2 (de) | 1994-04-11 | 2002-04-25 | Akzo Nobel Nv | Europäische Vakzinstämme des Fortplanzungs-Atmungs-Syndromsvirus des Schweins |
| US5788962A (en) | 1995-01-17 | 1998-08-04 | The Curators Of The University Of Missouri | DNA sequences coding for mycoplasma hyopneumoniae surface antigens, corresponding proteins and use in vaccines and diagnostic procedures |
| EP0732340B1 (en) | 1995-03-14 | 2004-06-09 | Akzo Nobel N.V. | Expression of porcine reproductive respiratory syndrome virus polypeptides in the same cell |
| US5885823A (en) | 1995-06-05 | 1999-03-23 | Nobl Laboratories, Inc. | Lawsonia intracellularis cultivation, anti-Lawsonia intracellularis vaccines and diagnostic agents |
| EP0835930B1 (en) | 1996-10-09 | 2001-01-31 | Akzo Nobel N.V. | European vaccine strains of the porcine reproductive and respiratory syndrome virus (PRRSV) |
| US6517843B1 (en) | 1999-08-31 | 2003-02-11 | Merial | Reduction of porcine circovirus-2 viral load with inactivated PCV-2 |
| UA78180C2 (uk) | 1997-10-03 | 2007-03-15 | Меріаль | Кільцевий вірус свині типу ii, вакцини та діагностичні реагенти |
| US6391314B1 (en) | 1997-10-03 | 2002-05-21 | Merial | Porcine circoviruses vaccines diagnostic reagents |
| US6943152B1 (en) | 1999-06-10 | 2005-09-13 | Merial | DNA vaccine-PCV |
| DE602004023094D1 (de) | 2003-07-25 | 2009-10-22 | Boehringer Ingelheim Vetmed | Lawsonia intracellularis europäischen ursprungs unür |
| US7833707B2 (en) | 2004-12-30 | 2010-11-16 | Boehringer Ingelheim Vetmedica, Inc. | Methods of overexpression and recovery of porcine circovirus type 2 ORF2 |
| US8834891B2 (en) * | 2005-03-14 | 2014-09-16 | Boehringer Ingelheim Vetmedica, Inc. | Immunogenic compositions comprising Lawsonia intracellularis |
| DK3766518T3 (da) | 2005-12-29 | 2026-04-13 | Boehringer Ingelheim Animal Health Usa Inc | Immunogen pcv2-sammensætning til mindskelse af kliniske symptomer hos grise |
| EP3868400A1 (en) * | 2005-12-29 | 2021-08-25 | Boehringer Ingelheim Animal Health USA Inc. | Multivalent pcv2 immunogenic compositions and methods of producing such compositions |
| PT2094872T (pt) | 2006-12-15 | 2017-04-27 | Boehringer Ingelheim Vetmedica Inc | Tratamento de porcos seropositivos para o anticorpo anti-pcv2 com antigénio de pcv2 |
| KR20100113582A (ko) | 2008-01-23 | 2010-10-21 | 베링거잉겔하임베트메디카인코퍼레이티드 | Ｐｃｖ2 마이코플라즈마 히오뉴모니에 면역원성 조성물 및 당해 조성물의 생산 방법 |
| US8444989B1 (en) | 2008-04-18 | 2013-05-21 | Boehringer Ingelheim Vetmedica Gmbh | One dose vaccination against mycoplasma infections of pigs |
| PH12013501708B1 (en) | 2011-02-17 | 2018-08-03 | Boehringer Ingelheim Vetmedica Gmbh | Commercial scale process for production of prrsv |
| HRP20151031T1 (hr) | 2011-02-17 | 2015-11-06 | Boehringer Ingelheim Vetmedica Gmbh | Novi europski soj prrsv |
| US9120859B2 (en) | 2012-04-04 | 2015-09-01 | Zoetis Services Llc | Mycoplasma hyopneumoniae vaccine |
| AR097762A1 (es) * | 2013-09-27 | 2016-04-13 | Intervet Int Bv | Formulaciones secas de vacunas que son estables a temperatura ambiente |
| TWI670085B (zh) * | 2014-02-19 | 2019-09-01 | 荷蘭商英特威國際公司 | 液體穩定之豬病毒疫苗 |
-
2021
- 2021-07-22 EP EP21752619.3A patent/EP4185321A2/en active Pending
- 2021-07-22 CA CA3185751A patent/CA3185751A1/en active Pending
- 2021-07-22 JP JP2023504581A patent/JP7657287B2/ja active Active
- 2021-07-22 BR BR112023001324A patent/BR112023001324A2/pt unknown
- 2021-07-22 KR KR1020237006573A patent/KR20230044474A/ko active Pending
- 2021-07-22 MX MX2023001024A patent/MX2023001024A/es unknown
- 2021-07-22 CN CN202180060299.8A patent/CN116157147A/zh active Pending
- 2021-07-22 AU AU2021311726A patent/AU2021311726A1/en active Pending
- 2021-07-22 US US18/003,056 patent/US20230241198A1/en active Pending
- 2021-07-22 WO PCT/US2021/042778 patent/WO2022020593A2/en not_active Ceased
-
2023
- 2023-01-12 CO CONC2023/0000299A patent/CO2023000299A2/es unknown
- 2023-01-12 CL CL2023000118A patent/CL2023000118A1/es unknown
-
2024
- 2024-11-05 JP JP2024193753A patent/JP2025026461A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| AU2021311726A1 (en) | 2023-02-09 |
| JP7657287B2 (ja) | 2025-04-04 |
| CA3185751A1 (en) | 2022-01-27 |
| WO2022020593A3 (en) | 2022-02-24 |
| KR20230044474A (ko) | 2023-04-04 |
| MX2023001024A (es) | 2023-02-15 |
| CO2023000299A2 (es) | 2023-01-26 |
| CN116157147A (zh) | 2023-05-23 |
| BR112023001324A2 (pt) | 2023-02-14 |
| WO2022020593A2 (en) | 2022-01-27 |
| EP4185321A2 (en) | 2023-05-31 |
| US20230241198A1 (en) | 2023-08-03 |
| JP2023535066A (ja) | 2023-08-15 |
| JP2025026461A (ja) | 2025-02-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2023000118A1 (es) | Vacuna porcina que combina una o más antígenos. | |
| GT201400212A (es) | Vacuna de combinación contra pcv/mycoplasma hyopneumoniae/srrp | |
| MX2019008974A (es) | Vacunas contra el coronavirus porcino. | |
| AR121361A1 (es) | Vacuna | |
| RU2010117614A (ru) | Авирулентная адъювантная живая вакцина против mycoplasma hyopneumoniae | |
| NI201400119A (es) | Vacuna de combinación contra pcv/mycoplasma hyopneumoniae | |
| JP2016531854A5 (https=) | ||
| MX376715B (es) | Vacuna contra el virus de la diarrea epidemica porcina. | |
| CR20140436A (es) | Vacuna de combinación contra mycoplasma hyopneumoniae | |
| PE20061398A1 (es) | Vacuna de toxoide de c. perfringens alfa | |
| CL2022000563A1 (es) | Desarrollo de una vacuna novedosa atenuada viva contra la peste porcina africana basada en la eliminación del gen i177l. | |
| RU2016110430A (ru) | Pcv2b дивергентная вакцинная композиция и способы её применения | |
| MX2021012695A (es) | Vacuna de subunidad del virus de la fiebre porcina clasica (csfv). | |
| RU2017124240A (ru) | СПОСОБ ПОЛУЧЕНИЯ ГОТОВОЙ К ПРИМЕНЕНИЮ КОМБИНИРОВАННОЙ ВАКЦИНЫ ПРОТИВ PCV2/M.hyo | |
| BR0204470A (pt) | Uso de flavivirus para a expressão de epitopos de proteìna e para o desenvolvimento de um novo virus vacinal vivo atenuado para imunização contra flavivirus e outros agentes infecciosos | |
| CO6361948A2 (es) | Uso de antigeno de mycoplasma bovis | |
| CO6290700A2 (es) | Una vacuna que comprende una emulsion y una bacterina tratada con calor que comprende una suspension de la bacteria muerta | |
| RU2018137034A (ru) | Комбинированная вакцина против вируса pcv2 и инфекции mycoplasma hyopneumoniae | |
| RU2018127403A (ru) | Поливалентная вакцина против hyo и ее применение | |
| MX371126B (es) | Vacuna para cerdos contra el sindrome reproductivo y respiratorio porcino y lawsonia intracellularis. | |
| MX2019012220A (es) | Vacunas que contienen patogenos de cerdo para uso no mixto asociado. | |
| BR112021026502A2 (pt) | Vírus de vacina de síndrome reprodutiva e respiratória porcina | |
| MX2023005049A (es) | Vacuna combinada para proteger a los cerdos contra diversos trastornos. | |
| BR112021019351A2 (pt) | Bidens pilosa e seus fitoquímicos para uso na prevenção e tratamento de diarreia | |
| UA122732U (uk) | Вакцина проти репродуктивно-респіраторного синдрому цирковірусної та парвовірусної інфекції свиней асоційована інактивована емульсована |